The perivascular sensory nerve Ca2+ receptor and blood pressure regulation a hypothesis

American Journal of Hypertension

Volumn 11, Issue 9, 1998, Pages 1117-1123

  Bukoski, Richard D ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ANIMAL CELL; BLOOD PRESSURE REGULATION; BLOOD VESSEL INNERVATION; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CARDIOVASCULAR RESPONSE; HUMAN; HUMAN CELL; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CALCIUM; HUMANS; NEURONS, AFFERENT;

EID: 0032168791     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00499-8     Document Type: Review

References (60)

1. 1. Berthelot A, Miss-Pages C, Gairard A: Metabolisme calcique et hypertension mineralocorticoide: effets de la parathormone et la thyrocalcitonine exogenes et des variations de'l'apport en calcium et en magnesium. Comptes rendus de seances de la Societe de Biologie. Extrait du Tome. 1977; no. 55:1101-1106.
2. 2. Berthelot A, Gairard A: Effect of parathyroidectomy on cardiovascular reactivity in rats with mineralocorticoid hypertension. Br J Pharmacol 1978;62:199-205.
3. 3. Ayachi S: Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rat. Metabolism 1979;28:1234-1238.
4. 4. McCarron DA, Yung NN, Ugoretz BA, Krutzik S: Disturbances of calcium metabolism in the spontaneously hypertensive rat. Hypertension 1981;3:I165-I167.
5. 2+-intake in the SHR. Am J Physiol 1986;251:H976-H983.
6. 6. DiPette DJ, Greilich P, Kerr N, et al: Systemic and regional hemodynamic effects of calcium supplementation in mineralocorticoid-salt induced hypertension. Hypertension 1989;13:77-82.
7. 7. Kageyama Y, Bravo EL: Neurohumoral and hemodynamic responses to dietary calcium supplementation in deoxycorticosterone-salt hypertensive dogs. Hypertension 1987;9:III166-III70.
8. 8. Peuler JD, Morgan DA, Mark AL: High calcium diet reduces blood pressure in Dahl salt-sensitive rats by neural mechanisms. Hypertension 1987;9:III159-III165.
9. 9. McCarron DA, Morris CD, Cole C: Dietary calcium in human hypertension. Science 1982;217:267-269.
10. 10. McCarron DA, Morris CD, Henry HJ, et al: Blood pressure and nutrient intake in the United States. Science 1984;224:1392-1398.
11. 11. Garcia-Palmeiri M, Costas R, Cruz-Vidal M, et al: Milk consumption, calcium intake, and decreased hypertension in Puerto Rico. Hypertension 1984;6:322.
12. 12. Kromhout D, Bosschiert E, Coulander C: Potassium, calcium, alcohol intake and blood pressure. The Zutphen study. Am J Clin Nutr 1985;41:1043-1304.
13. 13. McCarron DA, Morris CD: Blood pressure response to oral calcium in persons with mild to moderate hypertension. Ann Intern Med 1985;103:825-831.
14. 14. Weinberger MH, Wagner UL, Fineberg NS: The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. Am J Hypertens 1993;6:799-805.
15. 15. Zhou C, Fan S, Zhou L, et al: Clinical observation of treatment of hypertension with calcium. Am J Hypertens 1994;7:363-367.
16. 16. Takagi Y, Fukase M, Takata S, et al: Calcium treatment of essential hypertension in elderly patients evaluated by 24 h monitoring. Am J Hypertens 1991;4:836-839.
17. 17. Zoccali C, Mallamaci F, Delfino D, et al: Double-blind randomized, crossover trial of calcium supplementation in essential hypertension. J Hypertens 1988;6:451-455.
18. 18. Galloe AM, Graudal N, Moller J, et al: Effect of oral calcium supplementation on blood pressure in patients with previously untreated hypertension: a randomized, double blind, placebo-controlled, crossover study. J Human Hypertens 1993;7:43-45.
19. 19. Bucher HC, Cook RJ, Guyatt GH, et al: Effects of dietary calcium supplementation on blood pressure - a meta-analysis of randomized controlled trials. J Am Med Assoc 1996;275:1016-1022.
20. 20. Allender PS, Cutler JA, Frollmann D, et al: Dietary calcium and blood pressure - a meta-analysis of randomized clinical trials. Ann Int Med 1996;124:825-831.
21. 21. Levine RJ, Hauth JC, Curet LB, et al: Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
22. 22. Lopez-Jaramillo P, Narvaez M, Weigel RM, et al: Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-655.
23. 23. Bucher HC, Guyatt GH, Cook RJ, et al: Effect of calcium supplementation on pregnancy induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. J Am Med Assoc 1996;275:1113-1117.
24. 24. Appel LJ, Moore TJ, Obarzanek E, et al: A clinical trial of the effects of dietary patterns of blood pressure. N Engl J Med 1997;336:1117-1124.
25. 25. Bukoski RD, Ishibashi K, Bian K: Vascular actions of calcium regulating hormones. Semin Nephrol 1995;15: 536-549.
26. 26. Hatton DC, McCarron DA: Dietary calcium and blood pressure in experimental models of hypertension: a review. Hypertension 1994;23:513-530.
27. 27. McCarron DA, Pingree PA, Rubin RJ, et al: Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980;2:162-168.
28. 28. Resnick LM, Laragh JH, Sealey JE, et al: Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 1983;309:888-891.
29. 29. Resnick LM, Muller FB, Laragh JH: Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-654.
30. 30. Charbon GA: A rapid and selective vasodilator effect of parathyroid hormone. Eur J Pharmacol 1968;3:275-278.
31. 45Ca uptake by primary cultures of aortic myocytes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Biochem Biophys Res Commun 1987;146:1330-1335.
32. 32. Bukoski RD, Wagman DW, Wang D: Injection of 1,25 vitamin D enhances resistance artery contractile properties. Hypertension 1990;16:523-531.
33. 3 on myosin in arterial tree of rats. Am J Physiol:Cell Physiol 1995;269:C443-C450.
34. 2+ and force generation in resistance arteries. Am J Physiol (Heart) 1996;270: H230-H237.
35. 35. Locker FG: Hormonal regulation of calcium homeostasis. Nursing Clin N Am 1996;31:797-803.
36. 36. Bohr DF: Vascular smooth muscle: dual effect of calcium. Science 1963;19:597-599.
37. 37. Hollaway ET, Bohr DF: Reactivity of vascular smooth muscle in hypertensive rats. Circ Res 1973;33:678-685.
38. 38. Cow D: Some reactions of surviving arteries. J Physiol 1911;xlii:125-143.
39. 39. Webb RC, Bohr DF: Mechanism of membrane stabilization by calcium in vascular smooth muscle. Am J Physiol 1978;235:C227-C232.
40. 40. Wu C, Bohr DF: Mechanisms of calcium relaxation of vascular smooth muscle. Am J Physiol 1991;H1411-H1416.
41. 2+ modulate endothelium-dependent reactivity of resistance arteries of spontaneously hypertensive and normotensive rats. Clin Exp Hypertens 1993;15:849-866.
42. 2+. Am J Physiol (Heart Circ Physiol) 1995;269:H230-H238.
43. 2+-sensing receptor from bovine parathyroid. Nature 1993;366:575-580.
44. 2+, and other ions as extracellular (first) messengers. Physiol Rev 1991;71:371-411.
45. 45. Garrett JE, Capuano IV, Hammerland LG, et al: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995;270: 12919-12925.
46. 46. Garrett JE, Tamir H, Kifor O, et al: Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 1995;136:5202-5211.
47. 47. Riccardi D, Park J, Li WS, et al: Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci 1995; 92:131-135.
48. 48. Ruat M, Molliver ME, Snowman AM, et al: Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc Natl Acad Sci USA 1995; 92:3161-3165.
49. 49. Maggi CA, Meli A: The sensor-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol 1988;19:1-43.
50. 50. Burnstock G, Ralevic V: New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plastic Surg 1994;47:527-543.
51. 51. Supowit SC, Christensen MD, Westlund KN, et al: Dexamethasone and activators of the protein kinase A and C signal transduction pathways regulate neuronal calcitonin gene-related peptide expression and release. Brain Res 1995;686:77-86.
52. 2+-induced relaxation of isolated arteries. Hypertension 1997;30:1431-1439.
53. 2+-induced relaxation of rat mesenteric resistance arteries. FASEB J 1997;11:A488.
54. 54. Linhares MC, Kissinger PT: Determination of endogenous ions in intercellular fluid using capillary ultrafiltration and microdialysis probes. J Pharmaceut Biomed Anal 1993;11:1121-1127.
55. 55. Rasmussen P: The concentration of calcium, inorganic phosphate, and protein in the interstitial fluid of rats during hypercalcaemic and hypocalcaemic conditions. Calc Tiss Res 1972;9:200-206.
56. 56. Silver IA, Murrilss RJ, Etherington DJ: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988; 175:266-276.
57. 57. Schleiffer R, Galluser M, Rohr O, et al: Development of a technique for in situ studies of calcium absorption in the intestine of rats. Biomed Pharmacother 1993;47:19-23.
58. 58. Cowley AW, Roman RJ: The role of the kidney in hypertension. J Am Med Assoc 1996;275:1581-1589.
59. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297-1303.
60. 60. Nemeth EF: Calcium receptors as novel drug targets, in Bilezikian JP, Raisz LG, Rodan GA (eds): Principles of Bone Biology. Academic Press, San Diego, 1996, pp 1019-1035.